Biostatistics ▲ Sign in to save

• ▲ Paul Bergmans

  Medisch Coördinerend Centrum Omnes Medicine
  2.89k

  citations

  27

  h-index

  20

  Aachen papers
• ▲ Robert Wapenaar

  Medicine
  744

  citations

  12

  h-index

  3

  Aachen papers

2 results

• Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results

  2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access

  34

  citations
• Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study

  2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access

  24

  citations
• Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data

  2023 Lara D. Veeken article Medicine Spondyloarthritis Studies and Treatments Open access

  21

  citations
• Safety of ustekinumab in adolescent patients with moderate‐to‐severe plaque psoriasis: real‐world evidence from an ongoing European study (NCT03218488)

  2022 Journal of the European Academy of Dermatology and Venereology article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis Open access

  5

  citations
• Asian Subgroup Analysis of the REMISSIO Study: A Long-Term Efficacy and Safety Study of Paliperidone Palmitate 3-month Formulation in Patients with Stable Schizophrenia in a Naturalistic Clinical Setting

  2022 Clinical Psychopharmacology and Neuroscience article Medicine Schizophrenia research and treatment Open access

  5

  citations
• 649TiP PRIMORDIUM: A randomized, international, trial-in-progress of adding apalutamide to radiotherapy and an LHRH agonist in high-risk patients with PSMA-PET-positive hormone-sensitive prostate cancer

  2021 Annals of Oncology article Medicine Prostate Cancer Diagnosis and Treatment Open access cited by 1 patent

  1

  citations
• P271 To what extent are baseline characteristics in biologic-experienced patients with psoriatic arthritis associated with achievement of minimal disease activity at week 24 of guselkumab treatment: a post hoc analysis of the phase IIIb COSMOS clinical trial

  2022 Lara D. Veeken article Medicine Spondyloarthritis Studies and Treatments Open access

  0

  citations

7 results